These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35315752)

  • 1. [New and rediscovered treatments for tuberculosis].
    Kraef C; Lillebæk T; Andersen ÅB; Kirk O
    Ugeskr Laeger; 2022 Mar; 184(10):. PubMed ID: 35315752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of New Therapeutics to Meet the Current Challenge of Drug Resistant Tuberculosis.
    Sheikh BA; Bhat BA; Mehraj U; Mir W; Hamadani S; Mir MA
    Curr Pharm Biotechnol; 2021; 22(4):480-500. PubMed ID: 32600226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global Landscape of Tuberculosis Therapeutics.
    Tornheim JA; Dooley KE
    Annu Rev Med; 2019 Jan; 70():105-120. PubMed ID: 30403551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
    Chan ED; Strand MJ; Iseman MD
    Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TB Alliance regimen development for multidrug-resistant tuberculosis.
    Murray S; Mendel C; Spigelman M
    Int J Tuberc Lung Dis; 2016 Dec; 20(12):38-41. PubMed ID: 28240571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?
    Dheda K; Cox H; Esmail A; Wasserman S; Chang KC; Lange C
    Respirology; 2018 Jan; 23(1):36-45. PubMed ID: 28850767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and Treatment.
    Tiberi S; Zumla A; Migliori GB
    Infect Dis Clin North Am; 2019 Dec; 33(4):1063-1085. PubMed ID: 31668191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
    Yew WW
    Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatment options for multidrug-resistant tuberculosis.
    Field SK; Fisher D; Jarand JM; Cowie RL
    Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance.
    Lohrasbi V; Talebi M; Bialvaei AZ; Fattorini L; Drancourt M; Heidary M; Darban-Sarokhalil D
    Tuberculosis (Edinb); 2018 Mar; 109():17-27. PubMed ID: 29559117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bedaquiline: a novel antitubercular drug for multidrug-resistant tuberculosis.
    Nagabushan H; Roopadevi HS
    J Postgrad Med; 2014; 60(3):300-2. PubMed ID: 25121373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curving Tuberculosis: Current Trends and Future Needs.
    Rojano B; Caminero JA; Hayek M
    Ann Glob Health; 2019 Jan; 85(1):. PubMed ID: 30741506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bedaquiline: Current status and future perspectives.
    Khoshnood S; Goudarzi M; Taki E; Darbandi A; Kouhsari E; Heidary M; Motahar M; Moradi M; Bazyar H
    J Glob Antimicrob Resist; 2021 Jun; 25():48-59. PubMed ID: 33684606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to new drugs and the global drug-resistant TB crisis: a case series from KwaZulu-Natal, South Africa.
    Master I; Furin J
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):985-7. PubMed ID: 27287655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosis.
    Heyckendorf J; Olaru ID; Ruhwald M; Lange C
    Am J Respir Crit Care Med; 2014 Aug; 190(4):374-83. PubMed ID: 24941306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management.
    Pontali E; Visca D; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
    Curr Opin Pulm Med; 2018 May; 24(3):244-252. PubMed ID: 29470252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future treatments for tuberculosis.
    Lee A; Xie YL; Barry CE; Chen RY
    BMJ; 2020 Mar; 368():m216. PubMed ID: 32122882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of drug resistantTB in patients with HIV co-infection.
    Pontali E; Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
    Expert Opin Pharmacother; 2015; 16(18):2737-50. PubMed ID: 26478945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance in tuberculosis and options available.
    Chugh S
    J Indian Med Assoc; 2010 Feb; 108(2):106-8. PubMed ID: 20839567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.